SOPHiA GENETICS (SOPH) Short-term Investments (2020 - 2025)

SOPHiA GENETICS has disclosed Short-term Investments across 6 years of filings, most recently posting $87.3 million for Q4 2025.

• In Q4 2025, Short-term Investments fell 1.55% year-over-year to $87.3 million; the TTM figure through Dec 2025 stood at $87.3 million (down 1.55% YoY), while the FY2025 annual figure was $87.3 million, down 1.55% from the prior year.
• Short-term Investments came in at $87.3 million for Q4 2025 at SOPHiA GENETICS, down from $88.7 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $138.2 million in Q4 2023 to a low of $1.1 million in Q1 2023.
• Average Short-term Investments over 5 years is $57.0 million, with a median of $60.6 million recorded in 2022.
• The largest YoY upside for Short-term Investments was 698.46% in 2023 against a maximum downside of 98.19% in 2023.
• Over 5 years, Short-term Investments stood at $72.4 million in 2021, then sank by 76.08% to $17.3 million in 2022, then soared by 698.46% to $138.2 million in 2023, then sank by 35.84% to $88.7 million in 2024, then retreated by 1.55% to $87.3 million in 2025.
• Per Business Quant data, the three most recent Short-term Investments figures were $87.3 million in Q4 2025, $88.7 million in Q4 2024, and $138.2 million in Q4 2023.